ArticleBriefings in bioinformatics2025
Using a consensus machine learning approach to identify host biomarkers associated with treatment response in pulmonary tuberculosis.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The lack of reliable biomarkers to monitor treatment response constitutes a major challenge in tuberculosis (TB) management, often leading to under- or overtreatment with the standard six-month regimen. Here, we integrated amino acid and trace element profiles, along with four machine learning-based feature selection methods, to develop an evaluation model. Additionally, we investigated the dynamic expression patterns of genes associated with the identified features during TB treatment to gain functional insights. The consensus feature selection from the four methodologies identified 34 potential biomarkers. Notably, three trace elements-Antimony (Sb), Copper (Cu), and Strontium (Sr)-were consistently highlighted as significant biomarkers across all employed methods. Re-analysis of two public RNA-seq datasets revealed that genes associated with these three trace elements yielded higher Area Under Curve values in distinguishing cured TB from untreated TB. Subsequent gene expression profiling showed dynamic expression patterns for genes linked to these biomarkers, predominantly involving pathways of programmed cell death, signal transduction, and immune response. These findings suggest that the combination of Sb, Cu, and Sr may serve as a novel laboratory criterion for monitoring TB treatment response, providing a practical tool to guide clinical decisions and reduce adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.